Eli Lilly (LLY) trending upwards after Q1 earnings beat Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- Immunomedics (IMMU) up 34% after announcing yesterday afternoon that the FDA has approved Trodelvy for the treatment of adult patients with metastatic triple-negative breast cancer who have received at least two prior therapies for metastatic disease
UP AFTER EARNINGS -
- Eli Lilly (LLY) up 1%
- Blackstone (BX) up 2%
- Sleep Number (SNBR) up 22%
- Las Vegas Sands (LVS) up 11%
DOWN AFTER EARNINGS -
- Citrix (CTXS) down 4%
- Invesco (IVZ) down 4%
- Crocs (CROX) down 7%
- Discover (DFS) down 3%
ALSO LOWER -
- Target (TGT) down 6% after announcing extensions of enhanced team member wages and benefits, and providing business updates related to the impact from COVID-19
- Gap (GPS) down 6% after announcing it will furlough the majority of store teams, withdraw FY20 guidance. suspend its quarterly cash dividend for the remainder of FY20 and suspend stock repurchases
- iCAD (ICAD) down 9% after raising $12.5M in a registered direct offering
- Alteryx (AYX) down 4% after JPMorgan analyst Mark Murphy downgraded shares to Underweight from Neutral
Symbols:
IMMU LLY BX SNBR LVS CTXS IVZ CROX DFS TGT GPS ICAD AYX Keywords: Fly Intel, Wall Street, Top Stories, Stocks